Defiance Nasdaq 100 Target 30 Income ETF (QQQO)

Overview

The IncomeShares Nasdaq 100 Fund is a specialized exchange-traded fund (ETF) that aims to provide investors with a focused investment opportunity in the top 100 non-financial companies listed on the Nasdaq Stock Market. By targeting organizations that showcase strong financial health and potential for growth, this fund offers exposure to key sectors such as technology, consumer services, and healthcare. These sectors are predominant within the Nasdaq 100 index and include companies that are at the forefront of digital innovation, e-commerce, and biotechnology. The primary objective of the IncomeShares Nasdaq 100 Fund is to generate income through dividends, catering to income-seeking investors, while also providing opportunities for capital appreciation. The fund achieves diversification by investing across a wide range of leading companies, thereby reducing the risk associated with individual stocks. It plays a crucial role in the financial market by facilitating investor access to some of the most influential multinational corporations that drive market trends and contribute to economic growth.

Products and Services

• Exposure to Top 100 Non-Financial Companies on the Nasdaq:

This product offers investors the opportunity to invest in the top 100 non-financial companies that are listed on the Nasdaq Stock Market. These companies are leaders in industries that include technology, consumer services, and healthcare, representing sectors that are vital to current market trends and future economic growth.

• Income Generation Through Dividends:

The fund aims to provide a regular stream of income to its investors by distributing dividends. This is an attractive feature for income-focused investors who are looking for reliable dividend payments in addition to the potential for capital growth.

• Access to Cutting-edge Industries:

Investing in this ETF gives investors direct exposure to sectors that are at the forefront of digital innovation, e-commerce, and biotechnology. This not only includes established giants driving current market trends but also potentially high-growth companies that are shaping the future economy.

• Risk Mitigation Through Diversification:

By diversifying its investments across a broad range of top-performing companies within the Nasdaq 100 index, the fund reduces the risk associated with individual stocks. This diversified approach helps to mitigate specific company risks, making it a safer investment option for those looking to invest in the volatile tech and healthcare sectors, among others.

• Capital Appreciation Potential:

While the primary aim of the fund is to generate income, it also offers investors the potential for capital appreciation. By investing in companies with strong growth prospects, the fund seeks to provide long-term value growth in addition to dividend income, targeting both returns on investment and income generation.